Chagas Disease: Optimizing Care for Pregnant Women and Children
COURSE NUMBER: WB2745
PROGRAM DESCRIPTION: This course is designed to increase knowledge and change competency of congenital Chagas disease practices and strategies. Content is derived from epidemiologic information, evaluation and treatment recommendations, and case studies.
At the conclusion of the session, the participant will be able to:
1. Describe Chagas disease.
2. Explain the treatment options for Chagas disease.
3. Recognize the transmission and clinical features of congenital Chagas disease.
4. Describe the management of Chagas disease in pregnant and nursing mothers.
5. Discuss the diagnosis and management of infants of Chagas-positive mothers.
6. Describe the evaluation of family members of an individual diagnosed with Chagas disease.
7. Apply the course content to identify and manage congenital Chagas disease presented in the case studies.
Stephanie R. Bialek, MD, MPH, Branch Chief, CDC, Center for Global Health, Division of Parasitic Diseases and Malaria, Parasitic Diseases Branch
Susan P. Montgomery, DVM, MPH, Veterinary Medical Officer/Epidemiology Team Lead, CDC, Center for Global Health, Division of Parasitic Diseases and Malaria, Parasitic Diseases Branch
Kelly Stimpert, MPH (IHRC) provided leadership and expertise in development of the course.
ORIGINATION DATE: August 10, 2017
RENEWAL DATE: August 10, 2019
EXPIRATION DATE: August 10, 2021
HARDWARE/SOFTWARE: Computer Hardware; Internet connection; Browser
TARGET AUDIENCE: Physicians, Registered Nurses, Nurse practitioners
PREREQUISITES: Medical background/knowledge
FORMAT: Enduring Materials
CONTACT INFORMATION: Division of Parasitic Diseases and Malaria, Parasitic Diseases Branch (404) 718-4745
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this enduring material for a maximum of (1.25) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides (1.2) contact hours.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception that Lessons include discussion on treatment of congenital Chagas disease with nifurtimox, a drug which is not FDA approved. CDC has FDA permission to release this drug under IND mechanisms for compassionate use in the United States.
CDC did not accept commercial support for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
- Complete the activity
- Complete the Evaluation at www.cdc.gov/GetCE
- Pass the posttest at 80% at www.cdc.gov/GetCE
FEES: No fees are charged for CDC’s CE activities.